FULT vs TFSL

FULT presents a stark contrast between deep value and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock trades at a significant discount to both its Graham Number ($29.29) and Intrinsic Value ($61.36), the bearish technical trend and insider selling suggest caution. Strong earnings growth (46.5% YoY) and a consistent track record of beating estimates provide a bullish counter-narrative, but the low health score indicates underlying operational or financial instability. Overall, it is a high-value play with concerning health metrics.

TFSL exhibits significant fundamental deterioration, anchored by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect where the current price ($15.05) vastly exceeds both the Graham Number ($7.01) and Intrinsic Value ($2.24). The most critical red flag is an unsustainable dividend payout ratio of 353.13%, indicating the company is paying dividends far in excess of its earnings. This is compounded by a PEG ratio of 72.62 and stagnant earnings growth (-0.80% YoY), suggesting the stock is priced for growth that is not manifesting. Bearish insider activity from the CEO and CFO further reinforces a negative outlook.